New Key Statistics Module, Z-Score and F-Score
NAS:BGLC Key Ratios
Market Cap $ M | 8.83 |
Enterprise Value $ M | 3.06 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.94 |
Price/Sales | 0.79 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 9.00 |
EPS (TTM) $ | -0.18 |
Beneish M-Score | -3.92 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.17 |
EV-to-EBITDA | -1.22 |
PEG | -- |
Shares Outstanding M | 17.67 |
Net Margin (%) | -27.25 |
Operating Margin % | -26.82 |
Pre-tax Margin (%) | -26.98 |
Quick Ratio | 3.98 |
Current Ratio | 4.60 |
ROA % (ttm) | -26.58 |
ROE % (ttm) | -32.32 |
ROIC % (ttm) | -65.49 |
Dividend Yield % | -- |
Altman Z-Score | 3.42 |
BGLC Number of Guru Trades
BGLC Volume of Guru Trades
Gurus Latest Trades with NAS:BGLC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BGLC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BioNexus Gene Lab Corp Insider Transactions
No Available Data
News about NAS:BGLC
Total 0- 1